256 related articles for article (PubMed ID: 10430971)
21. Differences in survival between black and white patients with diabetic end-stage renal disease.
Cowie CC; Port FK; Rust KF; Harris MI
Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
[TBL] [Abstract][Full Text] [Related]
22. A familial risk of chronic renal failure among blacks on dialysis?
Ferguson R; Grim CE; Opgenorth TJ
J Clin Epidemiol; 1988; 41(12):1189-96. PubMed ID: 3210065
[TBL] [Abstract][Full Text] [Related]
23. Revisiting racial differences in ESRD due to ADPKD in the United States.
Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
[TBL] [Abstract][Full Text] [Related]
24. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa.
Han TM; Naicker S; Ramdial PK; Assounga AG
Kidney Int; 2006 Jun; 69(12):2243-50. PubMed ID: 16672914
[TBL] [Abstract][Full Text] [Related]
25. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
26. Familial aggregation of renal disease in a population-based case-control study.
Lei HH; Perneger TV; Klag MJ; Whelton PK; Coresh J
J Am Soc Nephrol; 1998 Jul; 9(7):1270-6. PubMed ID: 9644638
[TBL] [Abstract][Full Text] [Related]
27. Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy.
Foy MC; Estrella MM; Lucas GM; Tahir F; Fine DM; Moore RD; Atta MG
Clin J Am Soc Nephrol; 2013 Sep; 8(9):1524-32. PubMed ID: 23685946
[TBL] [Abstract][Full Text] [Related]
28. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
[TBL] [Abstract][Full Text] [Related]
29. Familial risk, age at onset, and cause of end-stage renal disease in white Americans.
Spray BJ; Atassi NG; Tuttle AB; Freedman BI
J Am Soc Nephrol; 1995 Apr; 5(10):1806-10. PubMed ID: 7787148
[TBL] [Abstract][Full Text] [Related]
30. HIV-associated nephropathy: case study and review of the literature.
Ross MJ; Klotman PE; Winston JA
AIDS Patient Care STDS; 2000 Dec; 14(12):637-45. PubMed ID: 11119430
[TBL] [Abstract][Full Text] [Related]
31. Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition.
Wei A; Burns GC; Williams BA; Mohammed NB; Visintainer P; Sivak SL
Kidney Int; 2003 Oct; 64(4):1462-71. PubMed ID: 12969167
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of family history of kidney disease and perception of risk for kidney disease: a population-based study.
Jurkovitz C; Hylton TN; McClellan WM
Am J Kidney Dis; 2005 Jul; 46(1):11-7. PubMed ID: 15983952
[TBL] [Abstract][Full Text] [Related]
33. Is the prevalence of HIV-associated nephropathy decreasing?
Ahuja TS; Borucki M; Funtanilla M; Shahinian V; Hollander M; Rajaraman S
Am J Nephrol; 1999; 19(6):655-9. PubMed ID: 10592359
[TBL] [Abstract][Full Text] [Related]
34. HIV-associated nephropathy: an urban epidemic.
Monahan M; Tanji N; Klotman PE
Semin Nephrol; 2001 Jul; 21(4):394-402. PubMed ID: 11455528
[TBL] [Abstract][Full Text] [Related]
35. Impact of birth weight on familial aggregation of end-stage renal disease.
Fan ZJ; Lackland DT; Kenderes B; Krisher J; Freedman BI
Am J Nephrol; 2003; 23(2):117-20. PubMed ID: 12481151
[TBL] [Abstract][Full Text] [Related]
36. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races.
Lucas GM; Lau B; Atta MG; Fine DM; Keruly J; Moore RD
J Infect Dis; 2008 Jun; 197(11):1548-57. PubMed ID: 18422458
[TBL] [Abstract][Full Text] [Related]
37. Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: has the outcome changed in the 1990s?
Ifudu O; Mayers JD; Matthew JJ; Macey LJ; Brezsnyak W; Reydel C; McClendon E; Surgrue T; Rao TK; Friedman EA
Am J Kidney Dis; 1997 Apr; 29(4):549-52. PubMed ID: 9100043
[TBL] [Abstract][Full Text] [Related]
38. Genetic analysis of nitric oxide and endothelin in end-stage renal disease.
Freedman BI; Yu H; Anderson PJ; Roh BH; Rich SS; Bowden DW
Nephrol Dial Transplant; 2000 Nov; 15(11):1794-800. PubMed ID: 11071967
[TBL] [Abstract][Full Text] [Related]
39. HIV-associated nephropathy and end-stage renal disease in children in the United States.
Ahuja TS; Abbott KC; Pack L; Kuo YF
Pediatr Nephrol; 2004 Jul; 19(7):808-11. PubMed ID: 15141343
[TBL] [Abstract][Full Text] [Related]
40. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
Freedman BI; Langefeld CD; Turner J; Núñez M; High KP; Spainhour M; Hicks PJ; Bowden DW; Reeves-Daniel AM; Murea M; Rocco MV; Divers J
Kidney Int; 2012 Oct; 82(7):805-11. PubMed ID: 22695330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]